FDA Approved: MOTPOLY XR — Supplemental Application (Aucta Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for MOTPOLY XR (lacosamide) from Aucta Pharmaceuticals, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• MOTPOLY XR (LACOSAMIDE)

Snippet

SUPPL AP for MOTPOLY XR (LACOSAMIDE)